RU2099067C1 - Method for producing medicinal preparation - Google Patents
Method for producing medicinal preparation Download PDFInfo
- Publication number
- RU2099067C1 RU2099067C1 RU93036517A RU93036517A RU2099067C1 RU 2099067 C1 RU2099067 C1 RU 2099067C1 RU 93036517 A RU93036517 A RU 93036517A RU 93036517 A RU93036517 A RU 93036517A RU 2099067 C1 RU2099067 C1 RU 2099067C1
- Authority
- RU
- Russia
- Prior art keywords
- extract
- alcohol
- medicinal preparation
- sugar syrup
- producing medicinal
- Prior art date
Links
Abstract
Description
Изобретение относится к медицине и касается лекарственных препаратов, обладающих неспецифическим действием. The invention relates to medicine and relates to drugs with a non-specific effect.
Известен препарат неспецифического действия "Пантокрин" ФС 42-2323-85, представляющий собой 10% -ную на 50%-ном этиловом спирте вытяжку из пантов пятнистого оленя, марала и изюбря. Known drug of nonspecific action "Pantocrine" FS 42-2323-85, which is a 10% extract on 50% ethanol extract from antler sika deer, deer and red deer.
Наиболее близким к предлагаемому средству является средство "Рантарин"-ВФС42 (постановление комиссии по гормональным препаратам фармкомитета Минздрава СССР от 24.04.84, протокол 11), представляющий собой жидкий экстракт 1:1 пантов северного оленя, выпускаемый в настоящее время в лекформе таблетках, покрытый оболочкой. Closest to the proposed remedy is Rantarin-VFS42 (a resolution of the Commission on Hormonal Preparations of the Pharmaceutical Committee of the USSR Ministry of Health dated 04.24.84, protocol 11), which is a liquid extract of 1: 1 antler of reindeer, currently produced in the form of tablets, coated shell.
Недостатками указанных средств является в первом случае, наличие спирта, что неприемлемо для лиц, склонных к алкоголизму и противопоказано для подросткового возраста, во втором случае форма средства в виде таблеток консервативна, т. к. не может быть использована для наружного применения. В итоге обе формы не могут служить основой для создания комплексных лекарственных средств на основе вытяжек из пантов. The disadvantages of these funds are in the first case, the presence of alcohol, which is unacceptable for people prone to alcoholism and is contraindicated for adolescents, in the second case, the form of the drug in the form of tablets is conservative, since it cannot be used for external use. As a result, both forms cannot serve as the basis for the creation of complex medicines based on extracts from antlers.
Цель изобретения получение бесспиртового экстракта из пантов оленя. The purpose of the invention is the production of alcohol-free extract from deer antlers.
Сущность предлагаемого средства заключается в следующем. Объемная доля этилового спирта в экстракте из пантов оленя замещаются сахарным сиропом. The essence of the proposed tool is as follows. The volume fraction of ethyl alcohol in the deer antler extract is replaced by sugar syrup.
Пример конкретного исполнения. Из 10 л экстракта из пантов оленя, полученного по одной из известных технологий, на вакуумном испарителе при температуре не выше 70oC отгоняли этиловый спирт. Полученные 5 л безалкогольного экстракта доводили до первоначального объема 5 л 80%-ного сахарного сиропа. Отогнанный спирт возвращали в следующий цикл для получения экстракта.An example of a specific implementation. Ethyl alcohol was distilled out of 10 l of deer antler extract obtained according to one of the known technologies using a vacuum evaporator at a temperature not exceeding 70 o C. The resulting 5 l of non-alcoholic extract was brought to the initial volume of 5 l of 80% sugar syrup. The distilled alcohol was returned to the next cycle to obtain the extract.
Экономическая эффективность. При сохранении всех лекарственных качеств экстракта из пантов экстракт на сахарном сиропе более доступен для населения. Цена за единицу массы экстракта на сахарном сиропе существенно ниже цены экстракта на этиловом спирте, т.к. последний многократно используется для вытяжки из пантов. Economic efficiency. While preserving all the medicinal qualities of the antler extract, sugar syrup extract is more accessible to the public. The price per unit mass of extract on sugar syrup is significantly lower than the price of extract on ethyl alcohol, because the latter is repeatedly used to extract from antlers.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU93036517A RU2099067C1 (en) | 1993-07-15 | 1993-07-15 | Method for producing medicinal preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU93036517A RU2099067C1 (en) | 1993-07-15 | 1993-07-15 | Method for producing medicinal preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU93036517A RU93036517A (en) | 1996-09-10 |
| RU2099067C1 true RU2099067C1 (en) | 1997-12-20 |
Family
ID=20145145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU93036517A RU2099067C1 (en) | 1993-07-15 | 1993-07-15 | Method for producing medicinal preparation |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2099067C1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000016787A1 (en) * | 1998-09-23 | 2000-03-30 | Lee Youn Soo | Antler herb medicine fermented with chicken gizzard and a method for preparation thereof |
| EP1232174A1 (en) * | 1999-11-18 | 2002-08-21 | Ceremedix, Inc | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US6890896B1 (en) | 1999-11-18 | 2005-05-10 | Ceremedix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
-
1993
- 1993-07-15 RU RU93036517A patent/RU2099067C1/en active
Non-Patent Citations (1)
| Title |
|---|
| Рантарин - ВФС42. Постановление комиссии по гормональным препаратам фармкомитета Минздрава СССР от 24.04.84. Протокол 11. * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000016787A1 (en) * | 1998-09-23 | 2000-03-30 | Lee Youn Soo | Antler herb medicine fermented with chicken gizzard and a method for preparation thereof |
| US6482443B1 (en) | 1998-09-23 | 2002-11-19 | Youn-Soo Lee | Antler herb medicine fermented with chicken gizzard and a method for preparation thereof |
| EP1232174A1 (en) * | 1999-11-18 | 2002-08-21 | Ceremedix, Inc | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| EP1232174A4 (en) * | 1999-11-18 | 2004-03-31 | Ceremedix Inc | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US6890896B1 (en) | 1999-11-18 | 2005-05-10 | Ceremedix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US7524819B2 (en) | 1999-11-18 | 2009-04-28 | Ischemix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US8034774B2 (en) | 1999-11-18 | 2011-10-11 | Ischemix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| US8772237B2 (en) | 1999-11-18 | 2014-07-08 | Ischemix, Inc. | Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Felipe et al. | Phytochemical analysis of Pfaffia glomerata inflorescences by LC-ESI-MS/MS | |
| Rush et al. | The comparative steady-state bioavailability of the active ingredients of Madecassol | |
| Emami et al. | Sesquiterpene lactone fraction from Artemisia khorassanica inhibits inducible nitric oxide synthase and cyclooxygenase-2 expression through the inactivation of NF-κB | |
| RU2099067C1 (en) | Method for producing medicinal preparation | |
| Soni et al. | Phyto-pharmacological potential of Zizyphus jujube: A review | |
| Mishra et al. | Adjuvant effect of aqueous extract of Rhodiola imbricata rhizome on the immune responses to tetanus toxoid and ovalbumin in rats | |
| KR870010870A (en) | Method of Preparation of Pharmaceutical Composition | |
| Yim et al. | Antiplatelet activity of acylphloroglucinol derivatives isolated from Dryopteris crassirhizoma | |
| Tyler et al. | Present status of injectable contraceptives: results of seven-years study | |
| Suh et al. | Chemical constituents identified from fruit body of Cordyceps bassiana and their anti-inflammatory activity | |
| ITTO910538A1 (en) | HONEY POWDER, EVEN IN TABLET FORM, AND RELATED PREPARATION PROCEDURES | |
| CN102755320B (en) | pharmaceutical composition and health food for treating arthritis | |
| ATE226814T1 (en) | PHARMACEUTICAL COMPOSITION PRODUCED BY ADDING A FLAVOR TO AN ACTIVE INGREDIENT | |
| CA2238278A1 (en) | Antigenic protein originating in malassezia | |
| KR20150041298A (en) | Composition comprising gintonin for neural progenitor cells proliferation or neurogenesis improvement | |
| RU93036517A (en) | MEDICINE | |
| Saber et al. | Detailed metabolite profiling and in vitro studies of Urospermum picroides as a potential functional food | |
| Choi et al. | Anti‐Inflammatory Activity of a Novel Acetylene Isolated from the Roots of Angelica tenuissima Nakai | |
| RU2018316C1 (en) | Agent having tonic and universally restorative action | |
| Hayakawa et al. | Radial distribution of amino acids in the milled rice kernel | |
| KR102356654B1 (en) | An anti-inflammatory and analgesic formula comprising propolis and goji berry | |
| KR102374956B1 (en) | A pharmaceutical composition for preventing osteoclast differentiation comprising a physiologically active substance derived from an Echinacea extract | |
| SU644830A1 (en) | Composition of ingredients for punch | |
| KR970000237A (en) | Composition for the Treatment of AIDS and Immune Function Enhancement | |
| CN1037322C (en) | Dispensation of Chinese herbs oral liquid adjuvant |